Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 12/20 | 0.34 |
| ▸ | ADRB1 | P08588 | 12/20 | 0.34 |
| ▸ | ADRB3 | P13945 | 12/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25144721 | 1.00 | ADRB2 (0.34) | ADRB2ADRB1ADRB3 | |
| SCHEMBL25144620 | 0.87 | — | — | |
| SCHEMBL25144643 | 0.84 | ADRB2 (0.31) | ADRB2ADRB1ADRB3 | |
| SCHEMBL25144614 | 0.81 | TSHR (0.40) | ADRB2ADRB1ADRB3 | |
| SCHEMBL25144693 | 0.77 | TLR2 (0.32) | — | |
| SCHEMBL19034592 | 0.73 | ADRB2 (0.37) | ADRB2ADRB1ADRB3 | |
| SCHEMBL19542989 | 0.71 | ADRB2 (0.31) | ADRB2ADRB1ADRB3 | |
| SCHEMBL22278963 | 0.70 | ADRB2 (0.31) | ADRB2ADRB1ADRB3 | |
| SCHEMBL25144632 | 0.69 | ADH1B (0.30) | — | |
| SCHEMBL25144538 | 0.69 | TSHR (0.33) | ADRB2ADRB1ADRB3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230119227-A1 | OLIGONUCLEOTIDE SYNTHESIS ON SOLID SUPPORT | INTEGRATED DNA TECHNOLOGIES, INC. | 2023-04-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230119227-A1 | OLIGONUCLEOTIDE SYNTHESIS ON SOLID SUPPORT | RNGTT, SSU72, NSUN2 | ADRB2 4792/4885ADRB1 4770/4885ADRB3 4815/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.